Regal Investment Advisors’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-63
Closed -$2K 1172
2015
Q2
$2K Hold
63
﹤0.01% 865
2015
Q1
$2K Hold
63
﹤0.01% 924
2014
Q4
$2K Hold
63
﹤0.01% 872
2014
Q3
$2K Hold
63
﹤0.01% 898
2014
Q2
$2K Sell
63
-1,337
-96% -$45.8K ﹤0.01% 862
2014
Q1
$52K Buy
1,400
+309
+28% +$11.3K 0.02% 342
2013
Q4
$42K Buy
1,091
+172
+19% +$5.43K 0.02% 315
2013
Q3
$25K Buy
+919
New +$21.8K 0.01% 430

Other funds holding WX

Regal Investment Advisors's WX Position: Q3 2015 in Review

Regal Investment Advisors sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q3 2015, closing a stake of 63 shares — an estimated $2K sold.

Regal Investment Advisors first reported a position in WX in Q3 2013 and held it in 8 quarters. The position peaked at $52K in Q1 2014. 151 funds tracked by Wall St. Rank hold WX as of Q3 2015.

  • Regal Investment Advisors reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q3 2015 after selling out during the quarter.
  • Regal Investment Advisors sold 63 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q3 2015, an estimated $2K.
  • Regal Investment Advisors first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2013 and held it in 8 quarters.
  • Regal Investment Advisors's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $52K in Q1 2014.
  • 151 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q3 2015.

Based on Regal Investment Advisors's 13F filing for Q3 2015, filed 12 Nov 2015.